Towards Understanding Behaviour and Emotions of Children with CLN3 Disease (Batten Disease): Patterns, Problems and Support for Child and Family

Int J Environ Res Public Health. 2022 May 12;19(10):5895. doi: 10.3390/ijerph19105895.

Abstract

The juvenile variant of Neuronal Ceroid Lipofuscinosis (CLN3 disease/Batten disease) is a rare progressive brain disease in children and young adults, characterized by vision loss, decline in cognitive and motor capacities and epilepsy. Children with CLN3 disease often show disturbed behaviour and emotions. The aim of this study is to gain a better understanding of the behaviour and emotions of children with CLN3 disease and to examine the support that the children and their parents are receiving. A combination of qualitative and quantitative analysis was used to analyse patient files and parent interviews. Using a framework analysis approach a codebook was developed, the sources were coded and the data were analysed. The analysis resulted in overviews of (1) typical behaviour and emotions of children as a consequence of CLN3 disease, (2) the support children with CLN3 disease receive, (3) the support parents of these children receive, and (4) the problems these parents face. For a few children their visual, physical or cognitive deterioration was found to lead to specific emotions and behaviour. The quantitative analysis showed that anxiety was reported for all children. The presented overviews on support contain tacit knowledge of health care professionals that has been made explicit by this study. The overviews may provide a lead to adaptable support-modules for children with CLN3 disease and their parents.

Keywords: Batten disease; Juvenile Neuronal Ceroid Lipofuscinosis; behaviour; emotion; quality of life; support.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Emotions
  • Family
  • Humans
  • Membrane Glycoproteins
  • Molecular Chaperones
  • Neuronal Ceroid-Lipofuscinoses*
  • Young Adult

Substances

  • CLN3 protein, human
  • Membrane Glycoproteins
  • Molecular Chaperones

Grants and funding

This study was funded by ZonMw (reference numbers: 60-6410098101 and 845006106). P.S.S was funded by Bartiméus Fund (reference number P00238).